Posts by: Marisa Wexler MS

Marisa Wexler MS

Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.

January 14, 2021January 14, 2021

Pooling Imaging Data May Make Multi-center Clinical Trials Easier

News

Imaging data of brain inflammation in people with amyotrophic lateral sclerosis (ALS) that is obtained using different tracers and imaging equipment can be combined using a technique called the ... Read more

January 6, 2021January 6, 2021

Human Cell Model Captures Brain and Muscle Interaction for 1st Time

News

A system using human cells to model how the brain controls muscle movement has been developed for the first time, and scientists expect it to aid in understanding neurological ... Read more

December 21, 2020December 21, 2020

Target ALS Awards 4 Grants for Work Into Biomarker Discovery

News

Target ALS, a nonprofit working to advance research, has awarded a second round of grants supporting four projects that aim to discover and develop biomarkers for amyotrophic lateral sclerosis ... Read more

December 15, 2020December 15, 2020

QurAlis Working on New ALS Therapy to Harness Benefits Without Side Effects

News

Researchers at QurAlis have discovered a molecule with the potential to act as a treatment for amyotrophic lateral sclerosis (ALS), in addition to a new therapeutic target for the ... Read more

December 9, 2020December 9, 2020

Ezogabine Decreases Motor Neuron Excitability in ALS Clinical Trial

News

The anticonvulsant ezogabine can significantly reduce abnormal motor neuron excitability in people with amyotrophic lateral sclerosis (ALS), a clinical trial has found. The findings support further investigation of ezogabine, ... Read more

December 7, 2020December 7, 2020

Bill Easing Access to Disability Benefits for ALS Patients Passes US Senate

News

The U.S. Senate has passed a bill that may make it easier for people with amyotrophic lateral sclerosis (ALS) to access disability benefits. The proposed legislation, the ALS Disability ... Read more

November 13, 2020November 13, 2020

Wearable Facial Sensor May Help ALS Patients More Easily Communicate

News

A lightweight, wearable sensor is being developed that can detect minute facial movements and translate them into messages, potentially helping people with amyotrophic lateral sclerosis (ALS) communicate more easily. ... Read more

November 12, 2020November 12, 2020

Combo Bone Marrow Cell Transplant Seen to Benefit Mice in ALS Model

News

Transplanting a combination of two types of modified bone marrow cells eased motor deficits and prolonged survival in a mouse model of amyotrophic lateral sclerosis (ALS), researchers reported. Their study, ... Read more

November 5, 2020November 4, 2020

NORD Hosting ‘RareLaunch’ Workshops to Help Start Rare Disease Non-profits

News, syndicated

The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of free virtual workshops in December, with the aim of empowering leaders to start non-profit ... Read more

October 28, 2020November 5, 2020

Possible Way Seen of Preventing Inflammation That Precedes ALS Onset

News

Toxic clumps due to the buildup of the TDP-43 protein can trigger the neuronal inflammation that precedes symptoms of amyotrophic lateral sclerosis (ALS) by activating an inflammatory signaling pathway called cGAS-STING, ... Read more

Pin It on Pinterest